While overall survival was not different between the groups (HR 0.62; 95% CI 0.36–1.07; p = 0.09; I 2 = 80%;), the subgroup analysis of studies employing plastic stents showed a trend toward better survival in the RFA-treated group (HR 0.42; 95% CI 0.22–0.80; p = 0.009; I 2 = 72%).
The results showed a trend to decrease for N 2a peak amplitude, while the N 2b peak showed significantly more variability (paired Student’s t -test, p = 0.009) at increasing frequency, increasing or decreasing its amplitude during the stimulation trains ( Table 2 and Figure 4 ).
However, the associations of these molar ratios with EDSS in patients showed a trend towards negative correlations (0/16/7, p = 0.009), and these associations with T25FWT showed a borderline tendency towards negative correlations as well (1/16/6, p = 0.061).
Catalase activity also showed a trend similar to that of GPx (ANOVA, F 4,20 = 293.2, p < 0.01; Tukey–Kramer’s test, Figure 4 c), although the differences in activity between the tissues were less than those observed for GPx activity. 4.
The simple effects of the CMJ showed a trend that PAPE peaked at T4 ( p < 0.01) and almost subsided at T12 ( p > 0.05) in ML and P conditions.
The excessive release of IL-22 in lung tissue may stimulate the expression of RegIIIγ in intestinal tissue via the circulation Compared with the normal group, the expression of IFN-γ in the lungs and intestines of the RSV-infected group showed a trend of first increasing and then decreasing, reaching a maximum value one the third day after infection, with a significant difference ( P < 0.01, Fig. 4A ).
PTH showed a trend to increase early, by 4 weeks, after the start of pegvisomant but was only significantly higher compared to pretreatment at 24 weeks of therapy ( P = .01). 25-hyroxy vitamin D levels also tended to increase early after the start of pegvisomant and were significantly higher than pretreatment at 8 ( P = .05) and 12( P = .01) weeks of therapy.
Changes in Absolute Cell Number of Dorsal Skin Tissue and ALN The absolute cell number of CD19+, CD4+, CD8+, CD4+/CD69+, and CD23+/B220+ for ALN showed a trend of significant increase in DNCB_CTL compared to NC/Nga_Nr ( ## p < 0.01 or ### p < 0.001 (compared with NC/Nga_Nr)).
Compared with standard risk patients, the high risk patients showed a trend towards having worse OS (HR: 44.905, 95% CI: 2.458–820.360; P = 0.01).
The StartReact effect, which measures the acceleration of a visual reaction time by a loud (startling) sound and has been proposed to assess reticulospinal pathways, 36 showed a trend to increase in the biceps muscle in pCF subjects ( STR_Bic , 38.7 ± 34.1 versus 25.1 ± 12.3 ms, P = 0.010) but did not survive correction for multiple comparisons and was not significantly different in the first dorsal interosseous ( STR_1DI ).
An interaction test revealed significant results for OS and showed a trend toward significance for PFS between primary tumor sidedness and the treatment arms in the respective study (OS: P = 0.01; PFS: P < 0.01); additionally, a significant interaction was observed between anti-EGFR and non-anti-EGFR treatment and PTS for both OS ( P < 0.010) and PFS ( P = 0.05).
Consistently, in this study, patients with different types of depression showed a trend of increasing remission rates at each point of visit during the study (p < 0.01), however, there was no significant difference among the three types of chronotypes at each visit point ( p > 0.05), which suggested that different chronotypes had no significant effect on the remission rate of depressive symptoms.
Pseudotumor cerebri patients showed a trend of lowered CSF protein concentrations ( p = 0.01).
When controlling for baseline symptoms, M100 did not improve the amount of variance explained in either ΔPANSS Positive (ΔR2 = 0.04; p = 0.10) or Negative (ΔR2 = 0.07; p = 0.08), although both showed a trend toward significance, while ΔPANSS General demonstrated a significant improvement (ΔR2 = 0.16; p < 0.01). 3.3 Scalp EEG predicting symptoms Regression analyses were repeated using FCz N100 from a subsample of participants with usable EEG (n = 24).
Furthermore, the percentage of cells assigned to each cell type in each sample was not significantly different between treatment groups ( Supplementary Table 3 ), except for excitatory cells subtype F showed a trend towards a higher percentage in CIE-treated mice (nominal p-value = 0.012) and OPCs that showed a trend towards a lower percentage in CIE-treated mice compared to controls (nominal p-value<0.05, Supplementary Fig. 2a , b ).
23.8 months, P < 0.0001) and showed a trend to improved PFS ( P = 0.013) compared to patients not achieving NED status (Supplementary Fig.
The level of PC education showed a trend where those with compulsory theoretical training were more likely to be in the upper quartile, whereas those without it were in the lower quartile ( p = 0.013); thus, the differences in curricula between universities with compulsory training (Messina and Palermo) and those without (Catania) could explain such differences.
Furthermore, the Chopart joint of the affected foot showed a trend towards reduced frontal plane ROM during the loading response ( p = 0.013) and a trend towards an increased ROM during the midstance phase ( p = 0.03).
In contrast, as our analysis showed a trend toward increasingly poorer prognoses as the time to spontaneous cessation increased (p=0.014), we cannot recommend long-term conservative treatment with the expectation of spontaneous cessation.
In the first line setting, although combination therapy generally showed a trend toward higher ORR across most mutation groups, statistical significance was observed only in the BRAF subgroup ( P = 0.014).
3E , r (15) = 0.646 , P = 0.005, P FDR = 0.031) mean patch-switching threshold, and showed a trend with the personal ( Fig. 3A , r (15) = 0.585, P = 0.014, P FDR = 0.05).
Long-term TTF users (>=12 months) showed a trend towards extended OS and PFS compared to shorter-term users, with a significantly lower adherence rate at 3 months in early discontinuation cases (p=0.014).
5.6 months, hazard ratio (HR): 0.653, 95% CI: 0.470–0.906, P=0.0102], furthermore, showed a trend towards improved OS (in PD-L1 positive subgroup: 32.8 vs. 19.5 months, HR: 0.615, 95% CI: 0.414–0.914, P=0.0148; in intent-to-treat (ITT) population: 33.1 vs. 23.5 months, HR: 0.691, 95% CI: 0.513–0.932, P=0.0145).
The proportion of this population among EpCAM-negative CTCs was significantly higher compared to EpCAM low and showed a trend-level increase compared to EpCAM high CTCs ( p = 0.0159 and p = 0.0637, relatively). 2.3.
EOI2 MRD negativity was associated with superior EFS (n = 413; 47.6% MRD negativity v n = 43; 16.3% MRD positivity; P < .0001) and OS (n = 413; 66.0% v n = 43; 27.9%; P < .0001), and showed a trend toward lower CIR (n = 392; 46.1% v n = 26; 65.4%; P = .016).